Treatments for COVID-19: synthesis of evidence
DOI:
https://doi.org/10.37497/ijhmreview.v6i1.200Keywords:
Coronavirus, Conduct, Medicines, Covid-19.Abstract
Objective: To compile the most cited studies, related to therapeutic proposals to fight coronavirus, contributing to clinical decision to treat patients affected by Covid-19. Method: Literature review, carried out using the free software Publish or Perish, which selects papers based on a quality indicator intitled “h index”. The search terms were “COVID-19” or "COVID 19” or “coronavirus” or “coronavirus” and “treatment”. The search took place on April 20, 2020, and included only articles published in 2019 and 2020. Results and Conclusion: The use of antibiotics and corticosteroids should be carefully evaluated. Hydroxychloroquine, heparin, ibuprofen, interferon alfa, lopinavir / litonavir, intravenous immunoglobulin and teicoplanin are the agents currently employed in the treatment of Covid-19. However, there are no controlled clinical studies that prove the effectiveness of the drugs mentioned.
Downloads
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms: The author(s) authorize the publication of the text in the journal; The author(s) guarantee that the contribution is original and unpublished and is not in the process of being evaluated by any other journal(s); The journal is not responsible for the opinions, ideas, and concepts contained in the texts, as these are the sole responsibility of their respective author(s); The editors reserve the right to make adjustments to the text in order to ensure that it adheres to the standards of the journal. Authors retain the copyrights and grant the journal the right of first publication, with the article simultaneously licensed under the Creative Commons Attribution License which allows the sharing of the article with the acknowledgment of authorship and initial publication in this journal. Authors are authorized to take additional contracts separately, for the non-exclusive distribution of the version of the article published in this journal (e.g. publication in an institutional repository or as a book chapter), with the acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal webpage) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of published work (See The Effect of Free Access at http://opcit.eprints.org/oacitation-biblio.html)
